Expert Meetings

8th Closed Scientific Expert Meeting of the Editorial Board

London, UK, 29th August 2024 (Educational supporters)

Candidate genes that reduce VLDL secretion without inducing fatty liver

Coronary inflammation: Insights from the fat attenuation index

Inhibition of apoC3 or ANGPTL3 for reduction of ASCVD?

See more

7th Closed Scientific Expert Meeting of the Editorial Board

Virtual meeting, 7th February, 2024 (Educational supporters)

Pamela Bowe Morris

Therapeutic options for the severely hypertriglyceridaemic patient: Now and in the future

ApoC3 as a therapeutic target for treatment of severe hypertriglyceridaemia
(ii) Olezarsen

ApoC3 as a therapeutic target for treatment of severe hypertriglyceridaemia
(i) Plozasiran

See more

6th Closed Scientific Expert Meeting of the Editorial Board

Amsterdam, The Netherlands, 24th August, 2023 (Educational supporters)

Keynote – On the atherogenicity of remnant particles: Novel genetic insights

Karin Bornfeldt

Insights into apoC3’s mechanism of action

Steven Grinspoon

CVD risk reduction in HIV infection: The REPRIEVE Trial

See more

5th Closed Scientific Expert Meeting of the Editorial Board

Virtual meeting, 19th April, 2023 (Educational supporters)

Transcriptional effects of lipolytic products: Relevance to the pathophysiology of ASCVD

Fibrates: Finished or still fighting?

Robert Konrad, Eli Lilly & Company

ANGPTL8: The third musketeer?

See more

4th Closed Scientific Expert Meeting of the Editorial Board

Barcelona, Spain, 26th August, 2022 (Educational supporters)

ApoCIII inhibition: Impact of TG lowering

ANGPTL3/8 inhibition: Clinical results

Arterial wall interactions of chylomicrons and VLDL

See more

3rd Closed Scientific Expert Meeting of the Editorial Board

Virtual meeting, 13th April, 2022 (Educational supporters)

Prof Erik Stroes

ApoCIII and ANGPTL3 inhibition: A breakthrough in lowering triglyceride-rich lipoproteins?

REDUCE-IT subgroup analyses: New insights

Dr Michael Miller

Omega-3 fatty acids for cardiovascular risk reduction: A long and winding road

See more

2nd Closed Scientific Expert Meeting of the Editorial Board

Virtual meeting, 18th October, 2021 (Educational supporters)

Keynote – TGRLs and remnants: How do we assess their risk?

Keynote – Pancreatitis: Genetic complexity

Keynote – Pancreatitis: Pathophysiology

See more

1st Closed Scientific Expert Meeting of the Editorial Board

Virtual meeting, 20th May, 2021 (Educational supporters)

Keynote – Role of triglyceride-rich lipoproteins in residual cardiovascular risk

Børge G Nordestgaard

Keynote – Remnant cholesterol

Keynote – Relevance of TRL and remnants in FH

See more

Educational partners and supporters

Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Ionis Logo

Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Kowa Logo